Statistics
Publications
1
Citations
16
H-Index
1
Active since
2020
Affiliations
MILI KAKADIA is an author at Rutgers, The State University of New Jersey specializing in inflammation-induced endothelial dysfunction, cytokine-mediated pathology, and immunopharmacology.
Publications per year
2020–2020
1
1
Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?
Mohsin Sheraz Mughal, Ikwinder Preet Kaur, MILI KAKADIA et al. · Cureus · 2020 · 16 citations · Full text
Medicine, Immunology, Pharmacology +17
1–1 of 1